When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
IMRA - Imara advances mid-stage study of IMR-687 in sickle cell disease
IMARA Inc.
Imara (NASDAQ:IMRA)has dosed first patient in Ardent Phase 2b trial of IMR-687 for adult patients with sickle cell disease. Topline data from the trial is expected in the next quarter.